RSV Vaccine Options for U.S. Seniors to Become Available
Pharmaceutical companies Pfizer and GlaxoSmithKline (GSK) have each developed a vaccine to protect older adults from a virus known as RSV. People over 60 are at significant risk of serious complications if they contract RSV. Fortunately, with the recent FDA approval of Pfizer’s Abrysvo vaccine
